Aetiology of peptic ulcer, J.J.Misiewicz; experimental studies with histamine H2-receptor antagonists, M.E.Parsons; mechanisms of parietal cell function, J.G.Forte et al; experimental studies with proton pump inhibitors, K.-F.Sewing and W.Beil; antisecretory treatment and predisposition to cancer, M.J.S.Langman; clinical evaluation of antisecretory agents, A.L.Blum et al; prostaglandins and mucosal protection - laboratory evidence versus clinical performance, C.J.Hawkey; action of antiacids - more than bulk neutralization?, F.Halter and S.K.Lam; mechanisms of action of non-antisecretory anti-ulcer drugs, R.F.McCloy; gastroduodenal mucosal integrity, injury and repair, W.Silen; peptic activity and the mucus-bicarbonate barrier, A.Allen et al; neural regulation of gastroduodenal secretion and mucosal protection, G.Flemstrom and S.O.Granstam; pro-ulcerogenic eicosanoids and related lipid mediators in gastric mucosal damage, B.J.R.Whittle and J.V.Esplugues; pharmacological intervention in intestinal ulcerative disease, B.M.Peskar; pharmacological modulation of cellular, vascular and motility factors, S.Szabo; stress ulceration and mucosal acid-base balance, R.Schiessel; peptide control systems of the gut as therapeutic targets, G.J.Dockray; modulation of cell turnover and mucosal growth, R.A.Goodlad and N.A.Wright; gastric protective and ulcer-healing action of epidermal growth factor, S.J.Konturek et al; strategies for the development of novel anti-ulcer drugs, A.Garner.
